← Back to all trials
Recruiting
NCT07671989
Period Pills for Menstrual Regulation: A New Reproductive Health Option
Conditions: Menstrual Regulation, Menstrual Health Intervention
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 100
Sponsor: University of California, San Francisco
Location: UCSF Advancing New Standards in Reproductive Health (ANSIRH) Oakland California
Summary
The Period Pills Study is a prospective observational study among people who decide to use a combination of mifepristone and misoprostol for menstrual regulation.
Eligibility Criteria
Inclusion Criteria:
* Be 18 years old or older
* Read and speak English
* Know the date of their last menstrual period within 2 days
* Have a period that is late by up to 21 days
* Must have had regular periods in the last 4 months
* Does not want to be pregnant
* Does not want to verify pregnancy status
* Understand that if they are pregnant, the pills will end their pregnancy
* Does not have contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone/misoprostol/prostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)
Exclusion Criteria:
* Under 18 years old
* Does not read and speak English
* Does not know the date of their last menstrual period within 2 days
* Has not had regular periods in the last 4 months
* Wants to be pregnant
* Wants to verify pregnancy status
* Does not display understanding that if they are pregnant, the pills will end their pregnancy
* Has any contraindications to mifepristone and misoprostol (Risk factors for ectopic pregnancy; history of bleeding disorder or anticoagulant therapy; history of chronic adrenal failure, long-term corticosteroid therapy; allergy to mifepristone/misoprostol/prostaglandins; history of hemorrhagic disorders or anticoagulant therapy; history of inherited porphyrias; has an IUD; currently use a contraceptive implant or injectable)
Source: ClinicalTrials.gov (NCT07671989). StuddyBuddy aggregates publicly available trial information.